Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals

June 27, 2017 at 7:58 am

Journal of Antimicrobial Chemotherapy June 2017 V.72 N.6 P. 1704-1708

EDITOR’S CHOICE

Matthew E. Falagas; Tilemachos Skalidis; Konstantinos Z. Vardakas; Nicholas J. Legakis; on behalf of the Hellenic Cefiderocol Study Group

Background: Cefiderocol (S-649266), a siderophore cephalosporin, utilizes a novel mechanism of entry into the periplasmic space of Gram-negative bacteria and is broadly stable to ESBLs and carbapenemases.

Methods: A collection of carbapenem-resistant Gram-negative bacteria isolated from clinical specimens in 18 Greek hospitals was tested for susceptibility to cefiderocol, meropenem, ceftazidime, cefepime, ceftazidime/avibactam, ceftolozane/tazobactam, aztreonam, amikacin, ciprofloxacin, colistin and tigecycline. Broth microdilution plates were used to determine MICs.

Results: In total 189 non-fermentative Gram-negative bacteria (107 Acinetobacter baumannii and 82 Pseudomonas aeruginosa) and 282 Enterobacteriaceae (including 244 Klebsiella pneumoniae, 14 Enterobacter cloacae and 11 Providencia stuartii) were studied. For both A. baumannii and P. aeruginosa the MIC90 of cefiderocol was 0.5 mg/L. For K. pneumoniae, E. cloacae and P. stuartii the MIC90 of cefiderocol was 1, 1 and 0.5 mg/L, respectively. Tigecycline was the second most active antibiotic, followed by colistin.

Conclusions: Cefiderocol exhibited greater antimicrobial activity in vitro against carbapenem-resistant Gram-negative bacteria than comparator antibiotics.

PDF

https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jac/72/6/10.1093_jac_dkx049/2/dkx049.pdf?Expires=1498653890&Signature=hIt3ISMinohn8k-dCvOh0jDafT3ltZvbrZ1Od8Adr-rNoG77p4hy~gnXRfLbbbwQQr0SNut0vK7GI71SJ-QOxCLiqwxXp85-EZTFDLs36j2VzZen1TwzpcPBFErIt5Jj1V0OKtHTp4~kxRyHS1u07WRtQixoAcViW5yEQcniymmNYL6~OqHBpqaFxMxo9EX1-bBgILzVAToQx2XMz8EUkRgfhSEdUuqoqRFyJM2mRpN~cWvHryiAhC2gkdgfRbrn9hs72yZ5fvqFU4tlslUb2vpOGqWKlndscU9b1MS0v8bbamFTKw6OTBsUEjCbo9kgTsyUKmx~oMVQl96BAmujYA__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q

Advertisements

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Epidemiología, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update.

WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases Candida auris candidaemia in Indian ICUs: analysis of risk factors


Calendar

June 2017
M T W T F S S
« May   Jul »
 1234
567891011
12131415161718
19202122232425
2627282930  

Most Recent Posts


%d bloggers like this: